Published January 1, 2010 | Version v1
Journal article

Delineating role of ubiquitination on nuclear factor-kappa B pathway by a computational modeling approach

  • 1. Cell Signaling and BioImaging Laboratory, Department of Bio and Brain Engineering, KAIST, Daejeon 305-701 (Korea, Republic of)
  • 2. KI for Bio Century, KAIST, Daejeon 305-701 (Korea, Republic of)
  • 3. Graduate School of Medical Science and Engineering, KAIST, Daejeon 305-701 (Korea, Republic of)

Description

Mutant ubiquitin found in neurodegenerative diseases has been thought to hamper activation of transcription factor nuclear factor-kappa B (NF-κB) by inhibiting ubiquitin-proteasome system (UPS). It has been reported that ubiquitin also is involved in signal transduction in an UPS-independent manner. We used a modeling and simulation approach to delineate the roles of ubiquitin on NF-κB activation. Inhibition of proteasome complex increased maximal activation of IKK mainly by decreasing the UPS efficiency. On the contrary, mutant ubiquitin decreased maximal activity of IKK. Computational modeling showed that the inhibition effect of mutant ubiquitin is mainly attributed to decreased activity of UPS-independent function of ubiquitin. Collectively, our results suggest that mutant ubiquitin affects NF-κB activation in an UPS-independent manner.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2009.10.155

Additional details

Identifiers

DOI
10.1016/j.bbrc.2009.10.155;
PII
S0006-291X(09)02146-9;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
391
Journal Issue
1
Journal Page Range
p. 33-37
ISSN
0006-291X
CODEN
BBRCA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
45020775
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
GENE REGULATION; INHIBITION; MUTANTS; NERVOUS SYSTEM DISEASES; SIGNALS; SIMULATION; TRANSCRIPTION FACTORS
Descriptors DEC
DISEASES; ORGANIC COMPOUNDS; PROTEINS

Optional Information

Copyright
Copyright (c) 2009 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.